3SBio Announces Strong 2026 Results and Global Expansion Efforts

This Data Is Locked!

This area is available only to Subscribers.

3S Bio, a biopharmaceutical company based in China, has reported its interim results for the first half of 2026. The company recorded revenue of RMB... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?